Dr. Reddy's Laboratories, Inc. v. Celgene Corporation > Summary
Court Case Number IPR2018-01504
Filing Date Aug 3, 2018
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesChristopher G. Paulraj, Tina E. Hulse, Grace Karaffa Obermann
Judge Writing the Final DecisionChristopher G. Paulraj
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53
Petitioner
Patent Owner
Petitioner Attorneys
4Dr. Reddy's Laboratories
Attorney Name: Brandon M. White
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Emily J. Greb
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Crystal R. Canterbury
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Marc R. Levin
Perkins Coie
Patent Owner Attorneys
8Celgene
Attorney Name: Frank C. Calvosa
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Matthew J. Hertko
Jones Day
Celgene
Attorney Name: Christopher J. Harnett
Jones Day
Celgene
Attorney Name: John Elsevier
Celgene
Celgene
Attorney Name: Cary Miller
Jones Day
Celgene
Attorney Name: Anthony M. Insogna
Jones Day
Related Patents
Doc No | Title | Issue date |
---|---|---|
09056120 | Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine | Jun 16, 2015 |